The Use of Death Certificate Data to Characterize Mortality Associated With Respiratory Syncytial Virus, Unspecified Bronchiolitis, and Influenza in the United States, 1999-2018
- PMID: 35968872
- PMCID: PMC9377031
- DOI: 10.1093/infdis/jiac187
The Use of Death Certificate Data to Characterize Mortality Associated With Respiratory Syncytial Virus, Unspecified Bronchiolitis, and Influenza in the United States, 1999-2018
Abstract
Background: Death certificate data can improve our understanding of the mortality burden associated with respiratory syncytial virus (RSV) and influenza.
Methods: We used International Classification of Diseases, Tenth Revision codes listed on death certificates to characterize deaths from 1999 to 2018 as RSV, influenza, and unspecified bronchiolitis. We described the distribution of each cause of death by age, sex, race/ethnicity, place of death, and contributing causes of death.
Results: Over the 20-year study period, RSV, bronchiolitis, and influenza were listed as the underlying causes of death on 932, 1046, and 52 293 death certificates, respectively. Children <1 year of age accounted for 39% of RSV and bronchiolitis deaths, while 72% of influenza deaths were in adults ≥65 years. Children <1 year were more likely to die outside of the hospital from RSV, bronchiolitis, or influenza compared to all causes (P < .01), and black infants had the highest mortality rate for all 3 causes. Most infants dying from RSV did not have a high-risk condition listed on the death certificate. Death certificates captured 20%-60% of estimated excess RSV-attributable mortality in infants and <1% in seniors.
Conclusions: Thorough reporting on death certificates is an important public health goal, especially as new therapeutics become available. Infants had higher odds of dying out of hospital from respiratory pathogens compared to other causes, and race/ethnicity alone did not explain this disparity.
Keywords: RSV; bronchiolitis; death certificates; excess mortality; infant mortality; influenza.
© The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
Conflict of interest statement
Potential conflicts of interest. C. L. H. received contract-based hourly fees from sanofi pasteur - Sanofi. S. S. C. is an employee of sanofi pasteur - Sanofi and may hold shares and/or stock options in the company. C. V. reports no potential conflicts of interest. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
Figures



Similar articles
-
Mortality Associated With Respiratory Syncytial Virus, Bronchiolitis, and Influenza Among Infants in the United States: A Birth Cohort Study From 1999 to 2018.J Infect Dis. 2022 Aug 15;226(Suppl 2):S246-S254. doi: 10.1093/infdis/jiac127. J Infect Dis. 2022. PMID: 35968877 Free PMC article.
-
Mortality Associated With Influenza and Respiratory Syncytial Virus in the US, 1999-2018.JAMA Netw Open. 2022 Feb 1;5(2):e220527. doi: 10.1001/jamanetworkopen.2022.0527. JAMA Netw Open. 2022. PMID: 35226079 Free PMC article.
-
Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children, 1979-1997.J Infect Dis. 2001 Jan 1;183(1):16-22. doi: 10.1086/317655. Epub 2000 Nov 10. J Infect Dis. 2001. PMID: 11076709
-
Mortality Among US Infants and Children Under 5 Years of Age with Respiratory Syncytial Virus and Bronchiolitis: A Systematic Literature Review.J Infect Dis. 2022 Aug 15;226(Suppl 2):S267-S281. doi: 10.1093/infdis/jiac226. J Infect Dis. 2022. PMID: 35968871 Free PMC article.
-
Systematic Literature Review of Respiratory Syncytial Virus Laboratory Testing Practices and Incidence in United States Infants and Children <5 Years of Age.J Infect Dis. 2022 Aug 15;226(Suppl 2):S213-S224. doi: 10.1093/infdis/jiac203. J Infect Dis. 2022. PMID: 35968874 Free PMC article.
Cited by
-
Mortality Associated With Respiratory Syncytial Virus, Bronchiolitis, and Influenza Among Infants in the United States: A Birth Cohort Study From 1999 to 2018.J Infect Dis. 2022 Aug 15;226(Suppl 2):S246-S254. doi: 10.1093/infdis/jiac127. J Infect Dis. 2022. PMID: 35968877 Free PMC article.
-
All Infants Are at Risk of Developing Medically Attended Respiratory Syncytial Virus Lower Respiratory Tract Infection and Deserve Protection.J Infect Dis. 2022 Aug 15;226(Suppl 2):S148-S153. doi: 10.1093/infdis/jiac244. J Infect Dis. 2022. PMID: 35968870 Free PMC article. No abstract available.
-
The Burden of Respiratory Syncytial Virus Lower Respiratory Tract Disease in Infants in the United States: A Synthesis.J Infect Dis. 2022 Aug 15;226(Suppl 2):S143-S147. doi: 10.1093/infdis/jiac211. J Infect Dis. 2022. PMID: 35968867 Free PMC article. No abstract available.
-
Quality of life burden on United States infants and caregivers due to lower respiratory tract infection and adjusting for selective testing: Pilot prospective observational study.Health Sci Rep. 2023 Jun 16;6(6):e1338. doi: 10.1002/hsr2.1338. eCollection 2023 Jun. Health Sci Rep. 2023. PMID: 37334041 Free PMC article.
-
Hospitalizations due to respiratory syncytial virus (RSV) infections in Germany: a nationwide clinical and direct cost data analysis (2010-2019).Infection. 2024 Oct;52(5):1715-1724. doi: 10.1007/s15010-023-02122-8. Epub 2023 Nov 16. Infection. 2024. PMID: 37973718 Free PMC article.
References
-
- Falsey AR, Hennessey PA, Formica MA, Cox C, Walsh EE. Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med 2005; 352:1749–59. - PubMed
-
- Branche AR, Saiman L, Walsh EE, et al. . Incidence of respiratory syncytial virus infection among hospitalized adults, 2017–2020. Clin Infect Dis 2022; 74:1004–11. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical